Skip to main content
Boston Scientific to acquire nVision Medical in $275M deal

Boston Scientific agreed to pay $150 million in cash plus up to $125 million if clinical and commercial milestones are met over four years for San Bruno, Calif.-based nVision Medical, a startup that offers a balloon for collecting cells from the fallopian tubes to help detect ovarian cancer. Boston Scientific is looking to conduct a 120-patient study for the device, which was already evaluated in three smaller studies.

Full Story: